首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1672998

預防疫苗市場按疫苗類型、疾病類型、分銷管道和地區分類

Preventive Vaccines Market, By Vaccine Type, By Disease Type, By Distribution Channel, By Geography

出版日期: 2025年02月20日 | 出版商:

Coherent Market Insights | 英文 173 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球預防疫苗市場規模估計為 554.1 億美元，預計到 2032 年將達到 1,073.5 億美元，2025 年至 2032 年的複合年成長率為 9.9%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	554.1億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	9.90％	2032 年金額預測	1073.5億美元

數字。 2025 年預防疫苗市場佔有率（按地區分類）

由於世界各地各種感染疾病負擔加重，全球預防疫苗市場正經歷成長期。預防疫苗是增強對特定疾病的免疫力並有助於預防未來感染的生技藥品。多年來，疫苗學的各種進步使得疫苗的開發能夠保護個人免受危及生命的疾病的侵害。此外，人們對疫苗接種認知的不斷提高和疫苗技術的不斷創新正在刺激對預防疫苗的需求。一些政府已經實施了國家疫苗接種計劃以擴大覆蓋率。此外，公共和私人醫療保健在感染疾病的支出增加也促進了預防疫苗市場的擴大。然而，開發新疫苗所涉及的高昂研發成本以及低收入國家缺乏認知是阻礙市場成長的一些因素。

市場動態

全球預防疫苗市場的成長主要受到目標感染疾病流行率不斷上升的推動。新興市場中與細菌和病毒感染相關的大量未滿足的醫療需求正在推動對免疫接種和疫苗接種計劃的需求。各國政府和非營利組織為加強疫苗接種計畫所做的各種努力正在促進預防性疫苗的接種。例如，印度的國家免疫計劃旨在免費提供針對12種危及生命的疾病的疫苗。免疫抗原性和穩定性提高的疫苗產品開發技術進步正在開啟新的成長機會。然而，預計在預測期內，與新疫苗研發、測試、臨床試驗和製造相關的高成本將在一定程度上抑制市場擴張。人們越來越重視開發聯合疫苗以降低疫苗接種成本，這將在未來幾年提供有利可圖的機會。

研究的主要特點

本報告對全球預防疫苗市場進行了詳細分析，並展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，涵蓋了全球預防疫苗市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球預防疫苗市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
透過全球預防疫苗市場分析中使用的各種策略矩陣，相關人員將發現決策更加容易。

公司簡介
- Sanofi
- Pfizer Inc.
- Merck &Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat BIoTech
- Regeneron Pharmaceuticals Inc.

第 10 章分析師觀點

興衰
一致的機會地圖

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5342

Global Preventive Vaccines Market is estimated to be valued at USD 55.41 Bn in 2025 and is expected to reach USD 107.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 55.41 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 107.35 Bn

Figure. Preventive Vaccines Market Share (%), By Region 2025

The global preventive vaccines market is witnessing a period of growth owing to the rising burden of various infectious diseases across the world. Preventive vaccines are biological preparations that enhance immunity against certain diseases and help prevent future infections. Over the years, various advancements in vaccinology have enabled the development of immunization to safeguard individuals from life-threatening illnesses. Moreover, growing awareness regarding immunization and continuous innovation in vaccine technologies are fueling the demand for preventive vaccines. Governments of several countries have implemented national immunization programs to promote vaccination coverage. Rising healthcare expenditures on communicable diseases from public and private sources are also contributing to the expansion of the preventive vaccines market. However, high research and development costs involved in new vaccine development and lack of awareness in low-income nations are some of the factors hindering the market growth.

Market Dynamics:

The global preventive vaccines market growth is primarily driven by the increasing prevalence of target infectious diseases. Significant unmet medical needs associated with bacterial and viral infections across the emerging nations are driving the demand for immunization and vaccination programs. Various initiatives taken by governments and non-profit organizations to strengthen national immunization programs have augmented the uptake of preventive vaccines. For instance, the National Immunization Program of India aims to provide vaccines against 12 life-threatening diseases free of cost. Technological advancements in vaccine product development with improved immunogenicity and stability have unlocked new growth opportunities. However, high costs associated with new vaccine R&D, testing, clinical trials, and production are expected to restrain the market expansion to some extent during the forecast period. Rising focus on development of combination vaccines to lower vaccination costs offers lucrative opportunities in the forthcoming years.

Key Features of the Study:

This report provides in-depth analysis of the global preventive vaccines market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global preventive vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Sanofi, Pfizer Inc., Merck & Co. Inc., GSK plc., Takeda Pharmaceutical Company Limited, AstraZeneca, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., Zydus Group, Moderna, Inc., Sinopharm Group Co. Ltd., Valneva SE, Serum Institute of India Pvt. Ltd., Johnson & Johnson Services, Inc., Bharat Biotech, and Regeneron Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global preventive vaccines market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive vaccines market.

Detailed Segmentation-

By Vaccine Type:
- Live/Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Others
By Disease Type:
- Pneumococcal
- Poliovirus
- Hepatitis
- Influenza
- Measles
- Rubella
- Others
By Distribution Channel:
- Public
- Private
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Pipeline Analysis
Epidemiology
Pricing and Brand Analysis
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Preventive Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Preventive Vaccines Market, By Vaccine Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Live/Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subunit Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toxoid Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preventive Vaccines Market, By Disease Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Poliovirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Measles
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rubella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preventive Vaccines Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preventive Vaccines Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co. Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.